Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.

Differential expression of Hox genes is associated with normal hematopoiesis, whereas inappropriate maintenance of Hox gene expression, particularly Hoxa7 and Hoxa9, is a feature of leukemias harboring mixed-lineage leukemia (MLL) mutations. To understand the pathogenic roles of Hox genes in MLL leukemias, we assessed the impact of Hoxa7 or Hoxa9 nullizygosity on hematopoietic progenitor compartments and their susceptibility to MLL-induced leukemias. Selective reductions in the absolute numbers of committed progenitors, but not of hematopoietic stem cells, distinguished Hoxa7- and Hoxa9-deficient mice. Megakaryocytic/erythroid progenitor (MEP) reductions in Hoxa7(-/-) mice correlated with reticulocytosis and thrombocytopenia without anemia. Conversely, Hoxa9(-/-) mice displayed marked lymphopenia and substantial reductions of common lymphoid progenitors (CLPs) and lymphoid precursors, in addition to significant reductions of common myeloid progenitors (CMPs) and granulocyte/monocyte progenitors (GMPs). In retroviral transduction/transplantation assays, Hoxa7- and Hoxa9-deficient progenitors remained susceptible to transformation by MLL-GAS7, which activates MLL through a dimerization-dependent mechanism. However, Hoxa7(-/-) or Hoxa9(-/-) progenitors were less efficient in generating transformed blast colony-forming units (CFUs) in vitro and induced leukemias with longer disease latencies, reduced penetrance, and less mature phenotypes. Thus, Hoxa7 and Hoxa9 contribute to hematopoietic progenitor homeostasis but are not necessary for MLL-GAS7-mediated leukemogenesis, yet they appear to affect disease latency, penetrance, and phenotypes consistent with their critical roles as downstream targets of MLL fusion proteins.

[1]  M. Cleary,et al.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. , 2003, Genes & development.

[2]  J. Hess,et al.  Dimerization of MLL fusion proteins immortalizes hematopoietic cells. , 2003, Cancer cell.

[3]  M. Cleary,et al.  Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. , 2003, Cancer cell.

[4]  I. Weissman,et al.  Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In Vivo , 2003, The Journal of experimental medicine.

[5]  S. Armstrong,et al.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. , 2003, Blood.

[6]  G. Getz,et al.  Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F. Weerkamp,et al.  Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development , 2003, Leukemia.

[8]  M. Cleary,et al.  Novel SWI/SNF Chromatin-Remodeling Complexes Contain a Mixed-Lineage Leukemia Chromosomal Translocation Partner , 2003, Molecular and Cellular Biology.

[9]  I. Weissman,et al.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. , 2003, Cancer cell.

[10]  M. García-Cuéllar,et al.  Transcriptional activation is a key function encoded by MLL fusion partners , 2003, Leukemia.

[11]  Chi Wai So,et al.  Common mechanism for oncogenic activation of MLL by forkhead family proteins. , 2003, Blood.

[12]  Ioannis Panagopoulos,et al.  Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13) , 2003, Genes, chromosomes & cancer.

[13]  Toshiki Mori,et al.  ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. , 2002, Molecular cell.

[14]  Thomas A Milne,et al.  MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.

[15]  M. Cleary,et al.  MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function , 2002, Molecular and Cellular Biology.

[16]  B. Owens,et al.  HOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis , 2002, Stem cells.

[17]  I. Weissman,et al.  Lineage infidelity in myeloid cells with TCR gene rearrangement: A latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[19]  I. Miura,et al.  Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15). , 2002, Blood.

[20]  Takuro Nakamura,et al.  t(7;11)(p15;p15) chronic myeloid leukaemia 
developed into blastic transformation showing a novel 
NUP98/HOXA11 fusion , 2002, British journal of haematology.

[21]  R. Humphries,et al.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. , 2002, Experimental hematology.

[22]  E. Lander,et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia , 2002, Nature Genetics.

[23]  K. Sano,et al.  Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1 , 2001, Leukemia.

[24]  C. Croce,et al.  Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality , 2001, Oncogene.

[25]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[26]  T. Rabbitts,et al.  Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene , 2000, The EMBO journal.

[27]  C. Meijer,et al.  The role of Homeobox genes in normal hematopoiesis and hematological malignancies , 1999, Leukemia.

[28]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[29]  M. Cleary,et al.  MLL rearrangements in haematological malignancies: lessons from clinical and biological studies , 1999, British journal of haematology.

[30]  M. Seto,et al.  Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells , 1999, Oncogene.

[31]  T. Shows,et al.  NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. , 1998, Cancer research.

[32]  J. Greer,et al.  Analysis of Hoxa7/Hoxb7 mutants suggests periodicity in the generation of the different sets of vertebrae , 1998, Mechanisms of Development.

[33]  D. Izon,et al.  Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. , 1998, Blood.

[34]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[35]  I. Weissman,et al.  Identification of a lineage of multipotent hematopoietic progenitors. , 1997, Development.

[36]  G. Sauvageau,et al.  Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. , 1997, Blood.

[37]  M. Capecchi,et al.  Targeted mutations in hoxa-9 and hoxb-9 reveal synergistic interactions. , 1997, Developmental biology.

[38]  U. Thorsteinsdóttir,et al.  Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia , 1997, Molecular and cellular biology.

[39]  U. Thorsteinsdóttir,et al.  Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. , 1997, Immunity.

[40]  Takuro Nakamura,et al.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.

[41]  A. Feinberg,et al.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia , 1996, Nature Genetics.

[42]  U. Thorsteinsdóttir,et al.  Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. , 1995, Genes & development.

[43]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[44]  David P. LeBrun,et al.  Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice , 1993, Cell.

[45]  J D Kemp,et al.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow , 1991, The Journal of experimental medicine.